The Use of Low-Dose Recombinant Tissue Plasminogen Activator to Treat a Preterm Infant with an Intrauterine Spontaneous Arterial Thromboembolism

Neonatal thromboembolic events are rare, and only a few cases of intrauterine spontaneous arterial thromboembolisms have been reported in the literature. Thrombolytic therapy with recombinant tissue plasminogen activator is usually the preferred treatment because it has a short half-life, fewer syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirelli, Yaşar, Tekgündüz, Kadir Şerafettin, Caner, İbrahim, Kara, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805322/
https://www.ncbi.nlm.nih.gov/pubmed/26377159
http://dx.doi.org/10.4274/tjh.2015.0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805322/
https://www.ncbi.nlm.nih.gov/pubmed/26377159
http://dx.doi.org/10.4274/tjh.2015.0016

Ejemplares similares